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Abstract
Insulin regulates the transcription of genes for hepatic glucose and lipid metabolism. We hypothesized that this action may
be impaired in hepatocytes from insulin resistant animals. Primary hepatocytes from insulin sensitive Zucker lean (ZL) and
insulin resistant Zucker fatty (ZF) rats in ad libitum or after an overnight fasting were isolated, cultured and treated with
insulin and other compounds for analysis of gene expression using real-time PCR. The mRNA levels of one insulin-induced
(Srebp-1c) and one insulin-suppressed (Pck1) genes in response to insulin, glucagon, and compactin treatments in
hepatocytes from ad libitum ZL and ZF rats were analyzed. Additionally, the effects of insulin and T1317 on their levels in
hepatocytes from ad libitum or fasted ZL or ZF rats were compared. The mRNA levels of Srebp-1c, Fas, and Scd1, but not that
of Insr, Gck and Pck1, were higher in freshly isolated hepatocytes from ad libitum ZF than that from ZL rats. These patterns of
Srebp-1c and Pck1 mRNA levels remained in primary hepatocyte cultured in vitro. Insulin’s ability to regulate Srebp-1c and
Pck1 expression was diminished in hepatocytes from ad libitum ZF, but not ZL rats. Glucagon or compactin suppressed
Srebp-1c mRNA expression in lean, but not fatty hepatocytes. However, glucagon induced Pck1 mRNA expression similarly in
hepatocytes from ad libitum ZL and ZF rats. Insulin caused the same dose-dependent increase of Akt phosphorylation in
hepatocytes from ad libitum ZL and ZF rats. It synergized with T1317 to induce Srebp-1c, and suppressed Pck1 mRNA levels
in hepatocytes from fasted, but not that from ad libitum ZF rats. We demonstrated that insulin was unable to regulate its
downstream genes’ mRNA expression in hepatocytes from ad libitum ZF rats. This impairment can be partially restored in
hepatocytes from ZF rats after an overnight fasting, a phenomenon that deserves further investigation.
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Introduction
The increased rate of metabolic diseases, such as obesity,
diabetes and cardiovascular disease, has become a major public
health concern [1,2]. The common characteristic of human
obesity and type 2 diabetes is insulin resistance [3]. Liver plays a
critical role in mediating glucose and lipid homeostasis regulated
by hormones and nutrients. Factors derived from adipose tissues,
such as free fatty acid [4], adipokines [5] and inflammatory
cytokines [6] have been proposed to be responsible for the hepatic
insulin resistance.
In liver and hepatocytes, insulin regulates the expression of a
variety of genes responsible for glycolysis, glycogenesis and
lipogenesis, and inhibits gluconeogenesis [7]. This insulin-regulated
hepatic gene expression, at least in part, is responsible for glucose
and lipid homeostasis [8,9]. When liver is insulin sensitive, insulin
induces glycolysis, lipogenesis and suppresses gluconeogenesis in
hepatocytes. For hepatic glucose metabolism, insulin increases the
expression of glucokinase gene (Gck) [10,11], the enzymeresponsible
for the first step of hepatic glycolysis. It suppresses the expression of
the cytosolic form of phosphoenolpyruvate carboxykinase (Pck1)
[12] and glucose 6-phosphatase catalytic subunit (G6pc) [7], the first
and last steps of gluconeogenesis, respectively. For hepatic lipid
metabolism, insulin increases the expression levels of sterol
regulatory element binding protein 1c gene (Srebp-1c) [13], a
member of sterol regulatory element-binding proteins (SREBPs)
which are critical transcriptionactivatorsfor hepaticcholesteroland
fatty acid biosynthesis, and their homeostasis [14]. In liver of
SREBP-1c deleted mice [15], the fasting-refeeding cycle no longer
appropriately regulated the expression levels of critical lipogenic
genessuchasfattyacid synthase(Fas)andstearoyl-CoA desaturase 1
(Scd1) [16,17]. When liver is insulin resistant, insulin no longer
suppresses gluconeogenesis, but still stimulates lipogenesis, creating
a vicious cycle that aggravates insulin resistance and ultimately
contributes to the onset of overt diabetes. The co-existence of
hepatic insulin resistance (elevated gluconeogenesis) and sensitivity
(elevated lipogenesis) at gene expression level has been observed in
rodent diabetic models [3,8]. However, the mechanism of this co-
existence of insulin sensitivity and resistance has not been revealed
[18].
The binding of insulin to its receptor initiates a cascade of signal
transduction events that lead to metabolic changes in its target
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stimulation are the phosphatidylinositol 3-kinase (PI3K)–AKT/
protein kinase B (PKB) pathway [20] and mitogen-activated
protein kinase (MAPK) pathway [21]. Recently, insulin regulated
Srebp-1c expression has been shown to be mediated by atypical
protein kinase C (PKC) [22,23] and mammalian target of
rapamycin complex (mTORC) 1 [24]. Elevated activity of PKCf
in Goto–Kakizaki type 2 diabetic rats has been attributed to the
excessive expression of hepatic Srebp-1c [25]. However, how these
signaling components cause the transcriptional changes remains to
be elucidated.
Zucker fatty (ZF) rats [26] and its sub strain Zucker diabetic
fatty rats [27] have been widely used as rat models for the
development of metabolic diseases [28,29] due to a missense
mutation in the extracellular domain of all leptin receptor isoforms
[30–32]. Insulin resistance in Zucker fatty or diabetic fatty rats has
been associated with higher basal insulin secretion caused by
increased fuel metabolism in pancreatic beta cells [33,34]. The
defects in pancreatic beta cell gene expression in Zucker diabetic
fatty rats [35,36], but not in obese ZF rats who have normal
glycemia [37], have been attributed to the development of
diabetes. However, the insulin-regulated gene expression in
hepatocytes from these insulin resistant animals has not been
studied.
Recently, in an attempt to understand how insulin induces
transcription of its responsive gene, we identified insulin responsive
elements in the Srebp-1c promoter as two liver X receptor (LXR)
binding sites and one sterol regulatory element [38]. This suggests
that insulin regulates the expression of its responsive genes after it
stimulates the synthesis of endogenous agonists for nuclear
receptor activation. It has been reported that the hepatic
expression of Srebp-1c was elevated in liver of Zucker diabetic
fatty rats [39]. We hypothesize that insulin-regulated expression of
genes involved in glucose and lipid metabolism may be altered in
liver of insulin resistant animals. To focus on insulin resistance and
obesity, but not diabetes, we analyzed insulin-regulated gene
expression in hepatocytes from ZF rats, which have hyperlipide-
mia, but normal glycemia [37]. Herein, we report the regulation of
the mRNA levels of Srebp-1c and Pck1, two representative insulin-




The reagents for primary hepatocyte isolation and culture have
been published [40]. Reagents for cDNA synthesis and real-time
PCR were obtained from Applied Biosystems (Foster city, CA).
Antibodies to phospho-Akt (Thr473) phospho-Akt (Ser473), and
total Akt, were obtained from Cell Signaling Technologies
(Danvers, MA). All other compounds were purchased from Sigma
(Saint Louis, MO) unless described otherwise.
Animals
Male ZL and ZF rats were bred at UTK or purchased from
Harlan Breeders (Indianapolis, IN). Rats were housed in colony
cages, and fed a standard rodent diet before isolation of primary
hepatocytes. All procedures were approved by the Institutional
Animal Care and Use Committee at the University of Tennessee
at Knoxville (Protocol number 1642).
Hepatocyte isolation and treatments
For primary hepatocyte isolation, ZL or ZF rats in ad libitum or
fasted overnight as indicated in the figure legends were euthanized
with carbon dioxide. A catheter was inserted into portal vein and
connected to a peristaltic pump with liver perfusion medium and
liver digestive buffer (Invitrogen). The inferior vena cava was cut
open to allow the outflow of the media at flow rate of 10 ml/min.
After completion of the digestion, livers were excised from the rat
and put into a tissue culture plate containing liver digest buffer for
removing connection tissues and allowing the release of hepato-
cytes. Medium containing hepatocytes were filtered through a cell
strainer and spun at 50 g for 3 minutes. The cell pellets were
washed twice with DMEM containing 5% fetal bovine serum, 100
units/ml sodium penicillin, and 100 mg/ml streptomycin sulfate.
After wash, the isolated hepatocytes were plated onto 60-mm
collagen type I coated dishes (2 to 3 million cells/dish) and
incubated in 4 ml of the same medium at 37uC and 5% CO2.
After incubation for 3–4 hours, the attached cells were washed
once with 4 ml of PBS, and incubated in medium A (medium 199
with 100 nM dexamethasone, 100 nM 3,39,5-triiodo-L-thyronine
(T3), 100 units/ml penicillin, and 100 mg/ml streptomycin sulfate)
containing 1 nM insulin for 14–16 hours until being used for the
indicated experiments. For the treatments, primary hepatocytes
were washed once with 3 ml of PBS and then incubated in 2 ml of
medium A containing indicated reagents for indicated time as
shown in the figure legends.
RNA extraction and Quantitative Real-Time PCR
Methods for preparation and analysis of RNA were described
previously [41]. The real time PCR primer sets for detecting Fas
(from Dr. Bruce Spigelman’s group), Gck, Pck1, and Srebp-1c [41]
have been published. The primer sets for Insr (forward 59-
CTGGAGAACTGCTCGGTCATT-39, and reverse 59-GGCC-
ATAGACACGGAAAAGAAG-39), and Scd1 (forward 59- AAGA-
TATCCACGACCCCAGCTA-39, and reverse 59- TGCAG-
CAGGGCCATGAG-39) were designed using Primer Express
software (Applied Biosystems). The gene expression level was
normalized to that of 36B4 unless described otherwise. Data were
presented as either the fold induction calculated from the DDCt
values [40] or the difference of the cycle threshold (DCt) numbers
between the experimental gene and 36B4, the invariable control
gene [41].
Immunoblot analysis
After indicated treatments in figure legends, primary hepatocytes
in a 60 mm dish were washed once with 3 ml PBS and scrapped
from the dish in 400 ml of whole-cell lysis buffer (1% Triton X-100,
10% glycerol, 1.0% IGEPAL CA-630, 50 mM Hepes, 100 mM
NaF, 10 mM EDTA, 5 mM Sodium orthovanadate, 1.9 mg/ml
aprotinin, 5 mg/ml leupeptin, 1 mM Benzamide, 2.5 mM DMSF,
pH 8.0). The lysates were allowed to sit on ice for at least
20 minutes before subjected to 200006 g centrifugation for
20 minutes. The protein content in the supernatant was determined
with PIERCE BCA protein assay kit (Rockford, IL). Proteins
(30 mg/lane) in whole cell lysates were separated on SDS/PAGE,
transferred to BIO-RAD Immun-Blot PVDF membrane (Hercules,
CA), and detected with primary antibodies according to the
protocols provided by the manufacturers. Bound primary antibod-
ies were visualized by chemiluminescence (ECL Western Blotting
Substrate; Thermo Scientific) using a 1:5,000 dilution of goat anti-
rabbit IgG (Upstate) conjugated to horseradish peroxidase. Filters
were exposed to X-ray films (Phenix Research Products, Candler,
NC) for protein band detection.
Statistics
Data were presented as means 6 SD. The number of
experiments represented the independent experiments using
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Levene’s test was used to determine homogeneity of variance
among groups using SPSS 19.0 statistical software and where
necessary natural log transformation was performed before
analysis. Multiple comparisons were analyzed by one-way
ANOVA. The Independent-Samples T-Test was used to compare
two conditions. Differences were considered statistically significant
at P,0.05.
Results
Elevated mRNA levels of Srebp-1c, Fas, Scd1, but not Insr,
Gck and Pck1 in isolated primary hepatocytes from ad
libitum ZF rats
To analyze the mRNA levels of hepatic insulin-regulated genes,
primary hepatocytes were isolated from ZL and ZF rats in ad
libitum condition. The mRNA levels of the representative control
and insulin-regulated genes involved in hepatic glucose and lipid
metabolism were subjected to real-time PCR analysis as shown in
Figure 1. The mRNA level of insulin receptor gene (Fig. 1A, Insr)
in freshly isolated primary hepatocytes of ZF rats was not
significantly different from that of ZL rats. The mRNA levels of
three lipogenic genes, Srebp-1c (Fig. 1B), Fas (Fig. 1C) and Scd1
(Fig. 1D) in the freshly isolated primary hepatocytes of ZF rats
were significantly higher than those of ZL rats. On the other hand,
the mRNA levels of two genes for glucose metabolism, Gck (Fig. 1E)
and Pck1 (Fig. 1F), in the freshly isolated primary hepatocytes of
ZF rats were similar to those of ZL rats. All these results
demonstrated that ZF rat hepatocytes had significantly higher
mRNA levels of Srebp-1c, Fas, and Scd1 than ZL rat hepatocytes
did, but not that of Insr, Gck, and Pck1.
The changes of Srebp-1c and Pck1 mRNA levels in
response to insulin stimulation were diminished in
hepatocytes from ad libitum ZF rats
To investigate insulin effects on gene expression in hepatocytes
from ZL and ZF rats, we examined the regulation of the mRNA
levels of two representative genes, one insulin-induced gene (Srebp-
1c) and one insulin-suppressed (Pck1) gene, which are robustly
regulated by insulin at transcriptional level in liver and primary
hepatocytes [24]. Figure 2A shows the 2DCt numbers of Srebp-1c
and Pck1 of the control groups in lean and fatty hepatocytes after
the overnight pretreatment. The Srebp-1c mRNA level in fatty
hepatocytes was higher than that in lean hepatocytes (25.261.5 vs
28.161.4). However, Pck1 mRNA in lean hepatocytes was not
significantly different from that in fatty hepatocytes (22.361.3 vs
21.760.7). These results demonstrated that the primary lean and
fatty hepatocytes after overnight pretreatment in culture still
maintained similar expression patterns as the freshly isolated
hepatocytes did as shown in Figure 1.
To compare the mRNA levels of Srebp-1c and Pck1 in lean and
fatty hepatocytes after insulin stimulation, their expression levels in
hepatocytes incubated in increasing concentrations of insulin were
determined as shown in Figure 2 B and C. Figure 2B shows that
the Srebp-1c mRNA level in hepatocytes from ad libitum ZL rats was
significantly induced by insulin at the lowest concentration tested
(0.1 nM). However, insulin failed to induce Srebp-1c mRNA
expression in hepatocytes from ad libitum fatty rats. Figure 2C
shows that insulin as low as 0.1 nM was sufficient to significantly
reduce the Pck1 mRNA level in lean hepatocytes (0.460.23-fold)
with further suppression at higher insulin concentrations (Fig. 2C).
In contrast, no significant reduction of Pck1 expression can be
observed until insulin reached 100 nM in fatty hepatocytes. The
Pck1 mRNA level in fatty hepatocytes at any insulin concentration
tested was significantly higher than that in lean hepatocytes at the
corresponding insulin dosage. All these results demonstrated that
insulin-mediated regulation of Srebp-1c and Pck1 mRNA expression
were significantly diminished or impaired in hepatocytes from fatty
rats in ad libitum.
The primary hepatocytes from ad libitum ZF rats lost
glucagon-suppressed Srebp-1c mRNA expression, but
retained the glucagon-induced Pck1 mRNA expression
To examine the responses of hepatocytes to other hormones,
hepatocytes from either lean or fatty rats in ad libitum were treated
with glucagon, an islet derived hormone antagonizing insulin
action [42]. Figure 3A shows that insulin induced the Srebp-1c
mRNA expression in lean hepatocytes as anticipated. Glucagon at
10 nM reduced basal and 100 nM insulin-induced Srebp-1c
mRNA expression to 0.760.04- and 1.260.4-fold of the control
value, respectively. However, Srebp-1c mRNA expression in fatty
hepatocytes was not affected by insulin, glucagon or insulin+glu-
cagon treatment. Figure 3B shows that the Pck1 mRNA expression
in lean hepatocytes was significantly suppressed in the presence of
insulin. Glucagon dramatically induced Pck1 mRNA expression to
2163.7- and 8.261.7-fold of the control value in the absence and
presence of insulin, respectively. In fatty hepatocytes, insulin at
100 nM still significantly suppressed Pck1 mRNA expression.
However, the remaining Pck1 mRNA in fatty hepatocytes was still
higher than that in lean hepatocytes (0.460.1- vs 0.0460.01- fold
of the control value). Despite the diminished response of Pck1
Figure 1. The mRNA levels of Insr (A), Srebp-1c (B), Fas (C), Scd1
(D), Gck (E), and Pck1 (F) in freshly isolated hepatocytes from ad
libitum Zucker lean and fatty rats. The primary hepatocytes were
isolated from Zucker lean and fatty rats in ad lib. The total RNA was
extracted and subjected to real-time PCR analysis. Results were
presented as means 6 SD of 2DCt (against 36B4) from five different
hepatocyte isolations from lean or fatty rats (* all P,0.05, for comparing
the 2DCt values of the indicated transcripts in hepatocytes from lean
rats with those from fatty rats using independent-samples t test).
doi:10.1371/journal.pone.0021342.g001
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hepatocytes, glucagon dramatically induced its expression by
2765.2- and 10.262.3-fold of the control value in the absence or
presence of insulin, respectively. The induction folds of Pck1
mRNA mediated by glucagon treatment in fatty hepatocytes were
not significantly different from those in lean hepatocytes without
or with insulin. These results again demonstrated impairment of
insulin-regulated Srebp-1c and Pck1 mRNA expression in hepato-
cytes from ZF rats in ad libitum. However, only the glucagon-
mediated reduction of Srebp1-c mRNA expression, but not
induction of Pck1, was diminished in the same cells. In addition,
the presence of insulin significantly attenuated glucagon-induced
Pck1 mRNA expression in hepatocytes derived from either lean or
fatty rats in ad libitum.
Blocking de novo cholesterol biosynthesis suppressed
basal and insulin-induced Srebp-1c mRNA expression in
hepatocytes from ZL, but not ZF rats in ad libitum
To assess the effects of endogenous cholesterol synthesis on the
Srebp-1c mRNA expression, hepatocytes from ZL and ZF rats in ad
libitum were treated without or with insulin in the absence or
presence of compactin, an inhibitor of 3-hydroxy-3-methylglu-
taryl-coenzyme A (HMG CoA) reductase, which has been shown
Figure 2. The maintenance of Srebp-1c and Pck1 mRNA
expression patterns in primary hepatocyte culture (A), and
the responses of Srebp-1c (B) and Pck1 (C) expression to insulin
in cultured hepatocytes from ad libitum Zucker lean or fatty
rats. Primary hepatocytes were isolated and pre-treated as described in
Materials and Methods before they were incubated in medium A
without or with increasing concentrations of insulin (0.01 to 100 nM) for
6 hours. Total RNA was extracted and subjected to real-time PCR
analysis. A. The expression levels of Srebp-1c and Pck1 in control
hepatocytes were expressed as 2DCt. B and C. The expression levels of
Srebp-1c (B) and Pck1 (C) in hepatocytes treated with vehicle control
was arbitrarily assigned a value of one for its corresponding cell type.
Results were plotted as fold induction and presented as means 6 SD of
five independent hepatocyte isolations for both lean and fatty rats
(n=5 for hepatocyte isolations; * for comparing the 2DCt values of lean
hepatocytes with fatty hepatocytes using independent-samples t test;
** for comparing fold induction values of the indicated transcripts in
lean hepatocytes with that in fatty hepatocytes at indicated insulin
concentrations using independent-samples t test; for Srebp-1c,c .b/a,
d.a, using one-way ANOVA; for Pck1,e .f, e.h, using one-way ANOVA;
all P,0.05,).
doi:10.1371/journal.pone.0021342.g002
Figure 3. The effects of insulin and glucagon on the mRNA
levels of Srebp-1c (A) and Pck1 (B) in hepatocytes from ad libitum
Zucker lean and fatty rats. Primary hepatocytes after pretreatment
as described in Materials and Methods were incubated in medium A
without or with 10 nM glucagon in the absence or presence of 100 nM
insulin for 6 hours. Total RNA was extracted and subjected to real-time
PCR analysis. The expression level of the indicated transcripts in the
control hepatocytes (lean or fatty) was arbitrarily assigned a value of
one for its corresponding cell type. Results were plotted as fold
induction and presented as means 6 SD of five independent
hepatocyte isolations for both lean and fatty rats (n=5 for hepatocyte
isolations; for Srebp-1c,b .a.c, b.d, b.b9, and c9.c, using one-way
ANOVA; for Pck1,g .h.e.f, g9.h9.e9.f9, and e9.e, using one-way
ANOVA; all P,0.05).
doi:10.1371/journal.pone.0021342.g003
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[43]. Figure 4A shows that insulin induced Srebp-1c mRNA
expression in lean, but not fatty hepatocytes, supporting results
shown in Figures 2 and 3. Compactin at 50 mM was sufficient to
significantly suppress both basal and insulin-induced Srebp-1c
mRNA expression in lean hepatocytes to 0.660.1- and 1.160.5-
fold of the control value, respectively. However, it did not
significantly affect Srebp-1c mRNA expression in fatty hepatocytes
without or with insulin. Compactin did not affect Pck1 mRNA
expression in hepatocytes from either lean or fatty ad libitum rats in
the absence or presence of insulin. These results demonstrated that
compactin treatment only inhibited basal and insulin-induced
Srebp-1c mRNA expression in lean, but not that of fatty
hepatocytes.
Insulin-induced phosphorylation of Akt was not altered
in hepatocytes from ZF rats in ad libitum
As the first step to investigate insulin signal transduction
pathway in hepatocytes from ZL and ZF rats in ad libitum, the
levels of phosphorylated and total Akt in them after insulin
stimulation for 10 minutes was compared. As shown in Figure 5A,
insulin started to induce noticeable phosphorylation of Akt on
Threonine 308 (Thr308) and Serine 473 (Ser473) as low as 0.01
and 0.001 nM in hepatocytes from either ad libitum ZL or ZF rats,
respectively. The phosphorylation of Thr308 and Ser473 in both
types of hepatocytes reached plateau at 10 and 1 nM insulin,
respectively. There was no obvious difference of Akt phosphor-
ylation on these two sites upon insulin stimulation for 10 minutes
in hepatocytes from ZL and ZF rats in ad libitum. To exclude the
variations of Immunoblot performed in different days, the
phosphorylation of Akt on Ser473 in three control groups or
1 nM insulin treatment groups of hepatocytes from either ZL or
ZF rats in ad libitum were compared side by side. As shown in
Figure 5B, the levels of Akt phosphorylation on Ser473 in lean
hepatocytes were similar to that in fatty hepatocytes from ad libitum
rats. There was no difference of total Akt protein levels in
hepatocytes from lean and fatty rats without or with insulin. These
results indicated that insulin-induced phosphorylation of Akt on
Thr308 or Ser473 was not impaired in hepatocytes from ad libitum
ZF rats.
Fasting restored the induction of Srebp-1c, and
suppression of Pck1 mRNA expression mediated by
insulin and T1317 in hepatocytes from ZF rats
To explore the effects of feeding condition on the insulin-
regulated gene expression, the mRNA levels of Srebp-1c and Pck1 in
response to insulin stimulation was analyzed in hepatocytes from
ZL and ZF rats in ad libitum or after an overnight fasting.
Hepatocytes were treated with insulin, T1317 and insulin+T1317,
and the expression levels of Srebp-1c and Pck1 mRNA were
examined as shown in Figure 6. Figure 6A shows that insulin or
Figure 4. The effects of compactin and insulin on the mRNA
levels of Srebp-1c (A) and Pck1 (B) in hepatocytes from ad libitum
Zucker lean and fatty rats. Primary hepatocytes after pretreatment
as described in Materials and Methods were incubated in medium A
without or with 50 mM compactin in the absence or presence of 1 nM
insulin for 6 hours. Total RNA was extracted and subjected to real-time
PCR analysis. The expression level of the indicated transcripts in the
control hepatocytes (lean or fatty) was arbitrarily assigned a value of
one for its corresponding cell type. Results were plotted as fold
induction and presented as means 6 SD of four independent
hepatocyte isolations for both lean and fatty rats (n=4 for hepatocyte
isolations; for Srebp-1c,b .a.c, b.d and b.b9, using one-way ANOVA;
for Pck1, e/g.f, and f9.f, using one-way ANOVA; all P,0.05).
doi:10.1371/journal.pone.0021342.g004
Figure 5. Immunoblot analysis of phospho-Akt and total Akt
levels in primary hepatocyes treated with increasing concen-
trations (A) or 1 nM (B) of insulin. After overnight pretreatment,
primary hepatocytes from ad libitum ZL and ZF rats were incubated in
medium A containing indicated concentrations of insulin for 10 min-
utes. After which, hepatocytes were washed once with 3 ml PBS and
lysed as described in Materials and Methods. Total protein (30 mg/lane)
was separated on 8% SDS/PAGE gels, detected by specific primary
antibodies as indicated, and visualized by chemiluminescence. A. The
levels of phoshpo-Akt(Thr308), phosphor-Akt(Ser473), and total Akt in
ad libitum lean and fatty hepatocytes treated with increasing
concentration of insulin (0 to 100 nM). Graph was the representative
of three independent experiments with similar results using hepato-
cytes isolated from three different ad libitum ZL or ZF rats in different
days. B. The levels of phospho-Akt(Ser473) and total Akt in ad libitum
lean and fatty hepatocytes treated without or with 1 nM insulin. Graph
represented three independent isolations of hepatocytes from different
ad libitum ZL or ZF rats in different days, which were run side by side.
doi:10.1371/journal.pone.0021342.g005
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from either ad libitum or fasted ZL rats. T1317 synergized with
insulin to induce Srebp-1c mRNA expression dramatically. The
induction folds of Srebp-1c mRNA mediated by T1317, but not
T1317+Insulin, were significantly higher in hepatocytes isolated
from fasted lean rats than that that from ad libitum lean rats
(37.265.1- vs 12.762.6-fold). In hepatocytes isolated from ad
libitum fatty rats, only insulin+T1317, but not insulin or T1317
significantly induced Srebp-1c mRNA expression. In hepatocytes
isolated from fasted fatty rats, insulin, T1317 and insulin+T1317
significantly induced Srebp-1c mRNA expression to 14.968.2-,
8.764.1-, and 80616.6- fold of the control value, respectively.
These numbers were significantly higher than those of the
corresponding groups in hepatocytes from ad libitum rats. The
induction folds mediated by T1317 and T1317+insulin in
hepatocytes from fasted ZF rats were still lower than those of
the corresponding treatments in hepatocytes from fasted ZL rats.
These results indicated that overnight fasting partially corrected
the impairment of insulin-induced Srebp-1c mRNA expression in
hepatocytes from ZF rats in ad libitum.
Figure 6B shows the Pck1 mRNA expression levels in
hepatocytes from ZL or ZF rats in ad libitum or an overnight
fasting treated without or with T1317 in the absence or presence
of insulin. T1317 at 1 mM did not affect the Pck1 mRNA
expression in hepatocytes from either ad libitum or fasted lean or
fatty rats in the absence or presence of insulin. Insulin at 1 nM
dramatically reduced the expression of Pck1 mRNA in hepatocytes
from ad libitum lean rats to the same extent as that in hepatocytes
from fasted lean rats. However, it only suppressed Pck1 mRNA
expression in hepatocytes from fasted fatty rats, but not that from
ad libitum fatty rats. Insulin+T1317 significantly reduced the Pck1
mRNA expression levels in hepatocytes from ad libitum lean, fasted
lean and fasted fatty, but not ad libitum fatty rats. Insulin and
insulin+T1317 significantly reduced the Pck1 mRNA expression
levels in hepatocytes from fasted fatty rats to 0.1760.08- and
0.1560.08-fold of the control group value, which are still
respectively higher than 0.0460.008- and 0.0460.015-fold (the
corresponding groups) in hepatocytes from fasted lean rats,
indicating partial improvement of insulin action in hepatocytes
from fasted fatty rats. These results demonstrated that an
overnight fasting of ZF rats restored the insulin-mediated
suppression of Pck1 mRNA expression in their hepatocytes.
Discussion
In the current study, we observed that the mRNA levels of Srebp-
1c, Fas and Scd1, but not that of Insr, Gck and Pck1, were higher in
freshly isolated hepatocytes from ad libitum ZF rats than those from
ad libitum ZL rats. It has been reported that ZF rats had
hyperinsulinemia, and elevated free fatty acid levels, but normal
plasma glucose levels in basal stage or after a glucose load [44].
Elevated expression of hepatic lipogenic genes have been observed
in ZF rats [45] and Zucker diabetic fatty rats [39,46]. Our results
matched these original observations. It has been shown that
hepatocytes isolated from rats in different nutritional conditions
retained their differences in glycogen deposition which is
influenced by the nutritional state [47]. The hepatocytes from ad
libitum fatty rats still retained the expression patterns of Srebp-1c
and Pck1 after overnight pre-treatment (Figure 2A). These results
indicated that our current experimental settings retained the
characteristics of the hepatocytes in vivo.
We have shown here that insulininduced Srebp-1c and suppressed
Pck1 mRNA expression in hepatocytes from ad libitum lean rats. In
hepatocytes from ad libitum fatty rats, insulin no longer induced
Srebp-1cmRNAexpressionatalltheconcentrationstested.Insulinat
100 nM suppressed Pck1 mRNA expression in fatty hepatocytes.
However, the degree of reduction in fatty hepaotcytes was not
comparable to that in lean hepatocytes (Figure 2). This indicates
that insulin-suppressed Pck1 mRNA expression was not completely
diminished in fatty hepatocytes, not as insulin-induced Srebp-1c was.
It has been shown that hepatocytes from the hyperinsulinemic ZF
rats had insulin binding equivalent to that of lean littermates and
had no reduction of insulin receptor at 10 weeks of age [48].
Therefore, low insulin-binding or receptor expression may not be
the reason for the diminished insulin-regulated Srebp-1c and Pck1
mRNA expression. This conclusion is supported by the insulin-
mediated Akt phosphorylation, which is similar in hepatocytes
isolated from ad libitum lean and fatty rats (Figure 5).
Insulin regulates the expression of hepatic genes involved in
glucose and lipid metabolism [7,8]. It induces Gck and suppresses
Pck1 [7], both involved in hepatic glucose metabolism. It also
induces the expression of Srebp-1c mRNA and in turn, increases
hepatic fatty acid biosynthesis [13]. If the hyperinsulinemia resulted
in the elevated mRNA levels of Srebp-1c, Fas and Scd1 in hepatocytes
from ad libitum fatty rats, the question becomes why it did not cause
elevation of Gck and reduction of Pck1 mRNA expression. It seems
Figure 6. The mRNA levels of Srebp-1c (A) and Pck1 (B) in
response to insulin, T1317 and insulin+T1317 treatments in
hepatocytes from ZL or ZF rats in ad libitum or after fasting for
overnight. Primary hepatocytes from rats on different feeding
conditions were isolated and pre-treated as described in Materials
and Methods. Hepatocytes were incubated in medium A without or
with 1 mM T1317 in the absence or presence of 1 nM insulin for 6 hours.
Total RNA was extracted and subjected to real-time PCR analysis. The
expression level of the indicated transcripts in the control hepatocytes
from lean or fatty rats in ad lib or overnight fasting was arbitrarily
assigned a value of one for its corresponding cell type and feeding
condition. Results were plotted as fold induction and presented as
means 6 SD of indicated numbers (in parenthesis after animal) of
independent hepatocyte isolations for both lean and fatty rats (for
Srebp-1c:d .b.c.a, g.a/f, j.h.i.a, and m.k/l.a, b.e, c.f, d.g,
h.b, h.k, j.m, k.e, l.f, and m.g, using one-way ANOVA; for Pck1:
a9/b9.c9/d9,a 9/h9.i9/j9,a 9/k9.l9/m9,f 9.c9,g 9.d9,f 9.l9, and g9.m9,
using one-way ANOVA; all P,0.05).
doi:10.1371/journal.pone.0021342.g006
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points that will specifically determine the responsiveness of a gene to
insulinin a certain condition. Indeed, bifurcation of insulinpathway
at mTORC1step hasbeenobserved inratliver whichseparated the
insulin-derived signals responsible for elevation of Srebp-1c mRNA
from those for reduction of Pck1 mRNA [24]. Whether any
branching point is responsible for the phenomenon observed here
remains to be investigated.
The diminished regulation of mRNA levels of Srebp-1c and Pck1
in response to insulin suggested that hepatocytes from ad libitum
fatty rats might have lost responses to other hormones. Glucagon,
a pancreatic hormone antagonizing insulin action [42], has been
shown to inhibit Srebp-1c and induce Pck1 mRNA expression in
hepatocytes in the absence or presence of insulin [49]. Therefore,
glucagon was used to treat hepatocytes from ad libitum lean or fatty
rats. Glucagon inhibited basal and insulin-induced Srebp-1c mRNA
expression in lean, but not in fatty hepatocytes from ad libitum rats.
When the Pck1 mRNA expression was analyzed, glucagon induced
its expression in both lean and fatty hepatocytes to the same extent
without or with insulin. These results demonstrated that in fatty
hepatocytes, Pck1 mRNA expression was still responsive to
glucagon stimulation. It is noteworthy that insulin attenuated
glucagon-mediated induction of Pck1 mRNA expression in fatty
hepatocytes to the same degree as that in lean hepatocytes
(Figure 3B). It appears that part of insulin signaling system
responsible for regulation of Srebp-1c and Pck1 mRNA expression
was impaired in fatty hepatocytes, whereas other parts responsible
for attenuation of glucagon action probably remained unchanged.
The results obtained from insulin dose-response curves of Akt
phosphorylation (Figure 5) supported this conclusion. Insulin dose-
dependently phosphorylated Akt on Thr308 and Ser473 to the
same extent in hepatocytes from ad libitum ZL or ZF rats. These
results indicated that activation of Akt by insulin remains the same
in lean and fatty hepatocytes. Components of insulin signal
transduction pathways other than Akt may be responsible for the
impaired response of Srebp-1c mRNA expression to insulin in fatty
hepatocytes. It has been shown that elevation of PKCf activity
contributed to the increased hepatic Srebp-1c expression in type 2
diabetic rats [22,23] [25]. In addition, insulin-induced Srebp-1c
mRNA expression in primary rat hepatocytes requires mTORC1
[24]. Whether any of these plays a role in the impairment of
insulin-mediated induction of Srebp-1c mRNA in primary hepato-
cytes from ad libitum fatty rats remains to be investigated.
As insulin induces Srebp-1c transcription via activation of liver X
receptor, a nuclear receptor activated by cholesterol derivatives
[50], the elevation of its mRNA expression in fatty hepatocytes
could be caused by the excessive synthesis of endogenous agonists
of LXR activation. However, when the endogenous cholesterol
biosynthesis was inhibited by HMG CoA reductase inhibitor
compactin [43], the Srebp-1c mRNA expression in fatty hepato-
cytes was not suppressed by it as it was in lean hepatocytes
(Figure 4). This suggests that the excessive synthesis of endogenous
ligands for LXR activation may not be the reason for
unresponsiveness of Srebp-1c mRNA expression to insulin in fatty
hepatocytes. Alternatively, another ligand not derived from
cholesterol might have activated LXR. The fact that T1317
alone, a synthetic ligand for LXR activation [51], could not
significantly induce Srebp-1c mRNA expression in hepatocytes
from ad libitum fatty rats (Figure 5A) suggests that the transcription
complex at Srebp-1c promoter in fatty hepatocytes was not sensitive
to changes of ligand for LXR activation as it was in lean
hepatocytes. It seems that Srebp-1c mRNA expression was locked in
a stage which no dynamic change was allowed. This might have
caused the unresponsiveness of Srebp-1c mRNA in fatty hepato-
cytes to positive and negative regulatory signals derived from
insulin and glucagon, respectively. Whether there is any change of
the activities of those transcription complexes on Srebp-1c and Pck1
promoter in fatty hepatocytes deserves further investigation.
As caloric restriction has been shown to increase insulin
sensitivity in human and animals [52–54], the ZL and ZF rats
were fasted for overnight and their hepatocytes were isolated for
measurement of their responses to insulin and T1317. In
hepatocytes from ad libitum or fasted lean rats, T1317 synergized
with insulin to induce Srebp-1c mRNA expression (Figure 6). Only
T1317 alone caused higher induction of Srebp-1c mRNA
expression in hepatocytes from fasted lean rats than that from ad
libitum lean rats, demonstrating limited effects of fasting on insulin-
regulated gene expression in hepatocytes from lean rats. However,
in hepatocytes from fasted fatty rats, insulin induced Srebp-1c and
suppressed Pck1 mRNA expression as it did in hepatocytes from
lean rats. In addition, T1317 also induced Srebp-1c mRNA
expression in hepatocytes from fasted fatty rats. The Srebp-1c
mRNA levels induced by insulin+T1317 in hepatocytes from
fasted fatty rats were similar to those from ad libitum lean rats,
significantly lower than those from fasted lean rats, and
significantly higher than those from ad libitum fatty rats. These
results demonstrated the partial restoration of insulin-regulated
gene expression in hepatocytes from fasted fatty rats. It has been
shown that an overnight fast was sufficient to mobilize fatty acid
from adipose tissues of fatty rats [37]. In addition, fasting has been
shown to partially restore insulin actions on adipocytes from
insulin resistant ZF rats [55]. The restoration of insulin-regulated
Srebp-1c and Pck1 mRNA expression in hepatocytes from fasting
fatty rat indicates that short term fasting was sufficient to modify
insulin action on hepatocytes from fatty rats. The molecular
mechanisms that led to the restoration of insulin action in fatty
hepatocytes deserve further investigation.
In summary, we have demonstrated that insulin-regulated Srebp-
1c and Pck1 mRNA expression was diminished in hepatocytes from
ad libitum fatty rats. This impairment was not due to any change of
Akt phosphorylation by insulin in hepatocytes from ZF rats. This is
the first time that the impairment of insulin action was shown at
the regulation of mRNA levels in ZF hepatocytes. The fact that a
simple overnight fasting partially restored insulin-regulated gene
expression in fatty hepatocytes indicates the existence of potential
pathway which can reverse the insulin resistance in hepatocytes
from Zucker fatty rats. The understanding of the underlying
molecular mechanisms will help us to combat metabolic diseases.
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